Buscar
Mostrando ítems 81-90 de 234
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
(B M J Publishing Group, 2020-08)
Objective: We aimed to characterise the liver tissue bacterial metataxonomic signature in two independent cohorts of patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) diagnosis, as differences in the ...
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
(Elsevier, 2020)
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence ...
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
(Soc EndocrinologyBristolInglaterra, 2007)
Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function
(BMJ PUBLISHING GROUP, 2004)
Background: Obese Zucker rats (ZR) have been used as an experimental model for non-alcoholic fatty liver disease and are particularly susceptible to various types of liver injury. Bile secretory function has not been ...
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
(2016)
Background & AimsMacrophage activation plays a key pathogenic role in experimental non-alcoholic fatty liver disease (NAFLD) and contributes to the progression of steatohepatitis (NASH) and fibrosis. We studied macrophage ...
Conjugated linoleic acid supplementation: lipid content and hepatic histology in healthy Wistar ratsSuplementação com ácido linoleico conjugado: conteúdo de lípides e histologia hepática de ratos Wistar saudáveis
(Sociedade Brasileira de Ciência e Tecnologia de Alimentos, 2011)
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
(ELSEVIER, 2006-12)
Non-alcoholic fatty liver disease (NAFLD) is emerging as a major cause of chronic liver disease in association with the rising prevalence of obesity and type 2 diabetes in the population. Oxidative stress and insulin ...
Hígado graso no alcohólico en consulta de gastroenterología
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2017-12-01)
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
(Elsevier Espana S.L., 2019)
Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in Latin-America, although data on prevalence is limited. Public health policies aimed at reducing the alarming prevalence of alcohol ...
Alteraciones de la tolerancia a la glucosa y frecuencia de síndrome metabólico en pacientes con enfermedad por hígado graso no alcohólico
(2006)
Background: Non alcoholic fatty liver disease (NAFLD) is associated to
diabetes mellitus, obesity, disturbances in serum lipid levels, insulin resistance and metabolic
syndrome. Aim: To assess glucose tolerance and the ...